ENETs 2015 Wrap Up

The 12th annual European Neuroendocrine Tumour Society (ENETS) scientific meeting was held in Barcelona, Spain in March. This meeting is recognised as the preeminent meeting where international NET experts gather to present and discuss the current research, treatments and issues regarding neuroendocrine cancers.

kjell Dr John Leyden and Prof Kjell Oberg

This year’s meeting was particularly exciting with the presentation of four abstracts based on the global NET patient survey. The global NET patient survey which was a collaboration between the International Neuroendocrine Cancer Alliance (INCA) of which the Unicorn Foundation is a founding member and Novartis Oncology. The Unicorn Foundation, through its networks, email, facebook, NET nurse support service and website was able to recruit 138 patients (7%) for this phenomenal and world first survey that has capture the ‘quintessential’ NET patient journey. We now have a body of evidence derived from 1927 respondents worldwide that has highlighted the myriad of issues with NET, but more importantly, the areas in which we can direct resources so as to improve the patient journey with NET.

inca mates Jo Grey (AMEND UK), Dr John Leyden (UF AUS), Maia Sissons (NET Patient Foundation, UK), Allen Wilson (Paratrooper, Ireland)

Dr John Leyden has been involved in this survey from its inception and has been representing ‘Oceania’ as an author on the abstracts and presentations that have been published. We encourage our NET specialists to reference this data and our NET patients to print the abstracts and use them to help educate others about NET and the impact that this has on many aspects of a NET patient’s life.

john Dr John Leyden

INCA and Novartis Global Survey Posters for download

https://neuroendocrine.org.au/wp-content/uploads/2020/03/ENETS-NETPatient-Experience_FINALPoster.pdf

https://neuroendocrine.org.au/wp-content/uploads/2020/03/ENETS-Poster_NET-Pt-Perspective_FNL.pdf 

https://neuroendocrine.org.au/wp-content/uploads/2020/03/ENETS-TimeToDiagnosis-FINALPoster.pdf 

https://neuroendocrine.org.au/wp-content/uploads/2020/03/ENETS_MDT_NETPtSurvey_FNL.pdf 

 

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

Neuroendocrine Cancer Day 2025

Racing for a Cure 2025

Celebrating Shane Kent’s Arch2Arc Journey and Fundraising

Sharon Rickard Completes Run Larapinta 2025!

Walk, run, or ride this March4NETs!

For its third year, March4NETs will run throughout March 2026.

Get involved and support the 31,000 Australians living with neuroendocrine cancer.